Acutus Medical Inc expected to post a loss of 64 cents a share - Earnings Preview

Acutus Medical

05/08/2023 01:40

* Acutus Medical Inc  AFIB.OQ   AFIB.O  is expected to show
a rise
in quarterly revenue when it reports  results on August 7. 
    * The Carlsbad California-based  company is expected to
report  a
11.1% increase in revenue to $4.529 million from $4.08 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. The company's guidance on April 20 2023, for
the period ended June 30, was for revenue between $4.10 million
and $4.20 million.
    * ​Refinitiv's mean analyst estimate for Acutus Medical Inc
is for
a loss of 64 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acutus
Medical
Inc is $1.75​, above​ its last closing price of $0.69. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.69       -0.69      -0.57     Beat    17.4
 Dec. 31 2023  -0.74       -0.71      0.41      Beat    158
 Sep. 30 2022  -0.82       -0.81      -0.72     Beat    10.9​
 Jun. 30 2022  -0.82       -0.80      -1.38     Missed  -73.4
 ​​Mar.        -0.94       -0.92      -1.00     Missed  -8.3
 31 2022                                                
 Dec. 31 2021  -0.95       -0.83      -1.12     Missed  -34.1​
 Sep. 30 2021  -0.85       -0.87      -0.94     Missed  -8.5
 Jun. 30 2021  -0.92       -0.84      -1.02     Missed  -21.7
 This summary was machine generated August 5 at 00:40 GMT.  All
figures in US dollars  unless otherwise stated